$PKE
PARK AEROSPACE CORP Stock $pke

$pke Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924022897 Filed on July 17, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$16.71M	$13.97M
YoY Change	33.88%	-10.17%
Cost Of Revenue	$11.95M	$9.871M
YoY Change	42.25%	-7.9%
Gross Profit	$4.757M	$4.099M
YoY Change	16.62%	-15.19%
Gross Profit Margin	28.47%	29.34%
Selling, General & Admin	$2.140M	$2.017M
YoY Change	15.49%	-22.87%
% of Gross Profit	44.99%	49.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$488.0K	$439.0K
YoY Change	43.95%	43.93%
% of Gross Profit	10.26%	10.71%
Operating Expenses	$2.140M	$2.017M
YoY Change	15.49%	-22.87%
Operating Profit	$2.617M	$2.082M
YoY Change	17.57%	-6.13%
Interest Expense	$245.0K	$339.0K
YoY Change	76.26%	4.63%
% of Operating Profit	9.36%	16.28%
Other Income/Expense, Net
YoY Change
Pretax Income	$2.816M	$1.369M
YoY Change	19.07%	-46.14%
Income Tax	$750.0K	$376.0K
% Of Pretax Income	26.63%	27.47%
Net Earnings	$2.066M	$993.0K
YoY Change	18.33%	-46.44%
Net Earnings / Revenue	12.36%	7.11%
Basic Earnings Per Share	$0.10	$0.05
Diluted Earnings Per Share	$0.10	$0.05
COMMON SHARES
Basic Shares Outstanding	20.25M	20.25M
Diluted Shares Outstanding	20.29M	20.37M

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$71.98M	$74.42M
YoY Change	-3.0%	-8.24%
Cash & Equivalents	$8.153M	$4.081M
Short-Term Investments	$63.83M	$70.34M
Other Short-Term Assets	$2.499M	$3.180M
YoY Change	-3.4%	18.17%
Inventory	$7.630M	$8.312M
Prepaid Expenses
Receivables	$10.91M	$11.39M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$93.03M	$97.30M
YoY Change	-1.7%	-5.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.89M	$22.19M
YoY Change	-8.71%	-8.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$87.00K	$83.00K
YoY Change	-13.86%	-20.95%
Total Long-Term Assets	$32.09M	$32.13M
YoY Change	-5.59%	-5.87%
TOTAL ASSETS
Total Short-Term Assets	$93.03M	$97.30M
Total Long-Term Assets	$32.09M	$32.13M
Total Assets	$125.1M	$129.4M
YoY Change	-2.72%	-5.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.700M	$2.201M
YoY Change	141.04%	-42.96%
Accrued Expenses	$1.348M	$1.513M
YoY Change	15.51%	-25.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.21M	$7.937M
YoY Change	50.4%	-18.99%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.222M	$1.198M
YoY Change	-32.56%	-89.26%
Total Long-Term Liabilities	$1.222M	$1.198M
YoY Change	-32.56%	-89.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.21M	$7.937M
Total Long-Term Liabilities	$1.222M	$1.198M
Total Liabilities	$14.86M	$17.74M
YoY Change	-6.6%	-22.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.38M	-$46.91M
YoY Change	7.23%	8.1%
Common Stock	$2.096M	$2.096M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$13.84M	$11.98M
YoY Change	14.95%	10.69%
Treasury Stock Shares
Shareholders Equity	$110.3M	$111.7M
YoY Change
Total Liabilities & Shareholders Equity	$125.1M	$129.4M
YoY Change	-2.72%	-5.83%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$2.066M	$993.0K
YoY Change	18.33%	-46.44%
Depreciation, Depletion And Amortization	$488.0K	$439.0K
YoY Change	43.95%	43.93%
Cash From Operating Activities	$1.446M	-$423.0K
YoY Change	-152.35%	-461.54%
INVESTING ACTIVITIES
Capital Expenditures	$194.0K	$12.00K
YoY Change	-6.28%	-92.81%
Acquisitions
YoY Change
Other Investing Activities	$7.214M	$481.0K
YoY Change	-12.43%	-98.17%
Cash From Investing Activities	$7.020M	$469.0K
YoY Change	-12.59%	-98.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.394M	-$2.532M
YoY Change	17.42%	-89.75%
NET CHANGE
Cash From Operating Activities	1.446M	-$423.0K
Cash From Investing Activities	7.020M	$469.0K
Cash From Financing Activities	-4.394M	-$2.532M
Net Change In Cash	4.072M	-$2.486M
YoY Change	166.67%	-255.47%
FREE CASH FLOW
Cash From Operating Activities	$1.446M	-$423.0K
Capital Expenditures	$194.0K	$12.00K
Free Cash Flow	$1.252M	-$435.0K
YoY Change	-142.17%	770.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	324000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2542000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	688000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1854000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20461000
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20526000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1854000	usd
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-03
CY2024Q2	dei	Amendment Flag AmendmentFlag	false
CY2024Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000076267
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	pke	Number Of Insurance Carriers NumberOfInsuranceCarriers	3	pure
CY2024Q2	pke	Number Of Units Covered Under General Liability Insurance Coverage NumberOfUnitsCoveredUnderGeneralLiabilityInsuranceCoverage	2	pure
CY2024Q2	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	0	usd
CY2024Q2	pke	Number Of Units Covered Under General Liability Insurance Coverage NumberOfUnitsCoveredUnderGeneralLiabilityInsuranceCoverage	2	pure
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4081000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	70337000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	132000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11386000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	8312000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3180000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	97296000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22185000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	81000	usd
CY2024Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9783000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	83000	usd
CY2024Q2	us-gaap	Assets Assets	129428000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	2096000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	170534000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46913000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2048000	usd
CY2024Q2	pke	Stockolders Equity Including Treasury Stock StockoldersEquityIncludingTreasuryStock	123669000	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	11982000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	111687000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	129428000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13970000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9871000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10718000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	4099000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	4833000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2017000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2615000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2082000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2218000	usd
CY2024Q2	pke	Storm Damage Charges StormDamageCharges	1052000	usd
CY2023Q2	pke	Storm Damage Charges StormDamageCharges	-0	usd
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	339000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1369000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	376000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	993000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20253000
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20371000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	993000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	223000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	716000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1216000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2570000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2024Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	993000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1854000	usd
CY2024Q2	pke	Noncash Storm Damage Charge NoncashStormDamageCharge	887000	usd
CY2023Q2	pke	Noncash Storm Damage Charge NoncashStormDamageCharge	0	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	439000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	305000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	89000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	218000	usd
CY2024Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000	usd
CY2024Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	49000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	237000	usd
CY2024Q2	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-0	usd
CY2023Q2	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-65000	usd
CY2024Q2	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2898000	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2564000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-423000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	117000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	167000	usd
CY2024Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2937000	usd
CY2023Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
CY2024Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3418000	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	26348000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	469000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	26181000	usd
CY2024Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2532000	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	23030000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1669000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2532000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24699000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2486000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1599000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6567000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4237000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4081000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5836000	usd
CY2024Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	608000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	70337000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	70644000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	73143000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2806000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	73755000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3111000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	31800000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	38537000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	70337000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6844000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5047000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	454000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	397000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1014000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	960000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	8312000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6404000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	15000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	13000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	81000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	107000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	124000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y7M6D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	109000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	708325
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.53
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2420000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1375
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.53
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	706950
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.53
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y8M26D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2488000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	521113
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.23
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M6D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1993000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	993000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1854000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20253000
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20461000
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	118000
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	65000
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20371000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20526000
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q2	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1500000
CY2024Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	129654
CY2023Q3	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	1278901
CY2023Q3	pke	Stock Repurchase Program Percentage Of Outstanding Shares Authorized To Be Repurchased StockRepurchaseProgramPercentageOfOutstandingSharesAuthorizedToBeRepurchased	0.063	pure
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20253361
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	376000	usd
CY2024Q2	pke	Income Tax Expense Benefit Discrete Amount IncomeTaxExpenseBenefitDiscreteAmount	19000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	688000	usd
CY2023Q2	pke	Income Tax Expense Benefit Discrete Amount IncomeTaxExpenseBenefitDiscreteAmount	37000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.275	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.271	pure
CY2024Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q2	us-gaap	Undistributed Earnings UndistributedEarnings	25000000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13970000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15551000	usd
CY2024Q2	pke	Storm Damage Charges StormDamageCharges	1052000	usd
CY2024Q2	pke	Revenue Delayed Delivery Due To Storm RevenueDelayedDeliveryDueToStorm	1800000	usd
CY2024Q2	pke	Payroll And Related Costs Incurred Storm Cleanup PayrollAndRelatedCostsIncurredStormCleanup	78000	usd
CY2024Q2	pke	Insurance Deductible InsuranceDeductible	2500000	usd
CY2024Q2	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>12. CONTINGENCIES</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Litigation</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is subject to a small number of immaterial proceedings, lawsuits and other claims related to environmental, employment, product and other matters. The Company is required to assess the likelihood of any adverse judgments or outcomes in these matters as well as potential ranges of probable losses. A determination of the amount of reserves required, if any, for these contingencies is made after careful analysis of each individual issue. The required reserves may change in the future due to new developments in each matter or changes in approach, such as a change in settlement strategy in dealing with these matters. The Company believes that the ultimate disposition of such proceedings, lawsuits and claims will not have a material adverse effect on the liquidity, capital resources, business, consolidated results of operations or financial position of the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Environmental Contingencies</span></i><i> </i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company and certain of its subsidiaries have been named by the Environmental Protection Agency (the “EPA”) or a comparable state agency under the Comprehensive Environmental Response, Compensation and Liability Act (the “Superfund Act”) or similar state law as potentially responsible parties in connection with alleged releases of hazardous substances at three sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under the Superfund Act and similar state laws, all parties who may have contributed any waste to a hazardous waste disposal site or contaminated area identified by the EPA or comparable state agency may be jointly and severally liable for the cost of cleanup. Generally, these sites are locations at which numerous persons disposed of hazardous waste. In the case of the Company’s subsidiaries, generally the waste was removed from their manufacturing facilities and disposed at waste sites by various companies which contracted with the subsidiaries to provide waste disposal services. Neither the Company nor any of its subsidiaries have been accused of or charged with any wrongdoing or illegal acts in connection with any such sites. The Company believes it maintains an effective and comprehensive environmental compliance program.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The insurance carriers which provided general liability insurance coverage to the Company and its subsidiaries for the years during which the Company’s subsidiaries’ waste was disposed at these three sites have in the past reimbursed the Company and its subsidiaries for 100% of their legal defense and remediation costs associated with <span style="-sec-ix-hidden:c583">two</span> of these sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company does <span style="-sec-ix-hidden:c584">not</span> record environmental liabilities and related legal expenses for which the Company believes that it and its subsidiaries have general liability insurance coverage for the years during which the Company’s subsidiaries’ waste was disposed at <span style="-sec-ix-hidden:c585">two</span> sites for which certain subsidiaries of the Company have been named as potentially responsible parties. Pursuant to such general liability insurance coverage, <span style="-sec-ix-hidden:c586">three</span> insurance carriers reimburse the Company and its subsidiaries for 100% of the legal defense and remediation costs associated with the two sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Included in selling, general and administrative expenses are charges for actual expenditures and accruals, based on estimates, for certain environmental matters described above. The Company accrues estimated costs associated with known environmental matters when such costs can be reasonably estimated and when the outcome appears probable. The Company believes that the ultimate disposition of known environmental matters will not have a material adverse effect on the Company’s results of operations, cash flows or financial position.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2	pke	Percentage Of Legal Defense And Remediation Costs Associated With Sites Reimbursed By Insurance Carriers PercentageOfLegalDefenseAndRemediationCostsAssociatedWithSitesReimbursedByInsuranceCarriers	1	pure

Files In Submission

Name	View Source	Status
0001437749-24-022897-index-headers.html	Edgar Link	pending
0001437749-24-022897-index.html	Edgar Link	pending
0001437749-24-022897.txt	Edgar Link	pending
0001437749-24-022897-xbrl.zip	Edgar Link	pending
ex_697987.htm	Edgar Link	pending
ex_697988.htm	Edgar Link	pending
ex_697989.htm	Edgar Link	pending
ex_697990.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pke-20240602.xsd	Edgar Link	pending
pke20240602_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
pke-20240602_def.xml	Edgar Link	unprocessable
pke-20240602_cal.xml	Edgar Link	unprocessable
pke-20240602_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
pke20240602_10q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pke-20240602_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PKE
PARK AEROSPACE CORP Stock $pke

2024 Q3 Form 10-Q Financial Statement

#000143774924022897 Filed on July 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKE PARK AEROSPACE CORP Stock $pke

2024 Q3 Form 10-Q Financial Statement

#000143774924022897 Filed on July 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKE
PARK AEROSPACE CORP Stock $pke